Otradi
Oregon Translational Research and Drug Development Institute (OTRADI)
OTRADI's foundation is based on a partnership between university scientists and researchers, bioscience and pharmaceutical companies, and the state of Oregon. OTRADI makes tools (expertise, equipment, analysis), which were previously unavailable or prohibitively expensive, readily available and accessible to Oregon's scientific investigators.
In addition, OTRADI works with university researchers and private bioscience companies to accelerate and advance the development and commercialization of new infectious disease therapeutics, vaccines and diagnostics.
- Leveraging Oregon's Research Strengths: With its combination of $80 million in infectious disease research funding, more than 70 PhDs involved in infectious disease studies, and one-of-a-kind facilities such as OHSU's primate center, Oregon is uniquely well-situated to meet the growing needs of the infectious disease market.
- OTRADI's Unique Contribution: OTRADI provides the previously missing components — a state-of-the-art translational facility, as well as high-throughput drug screening, and commercialization capabilities — necessary to translate Oregon's university research into tomorrow's drugs, vaccines, and diagnostics. In addition, OTRADI is building a library of potential therapeutic targets and chemical compounds that show promise as future development opportunities. Researchers at Oregon universities and companies can leverage OTRADI's cutting-edge, world-class scientific equipment and expertise to: 1) attract more/new federal funding for drug discovery, 2) increase the speed, number and quality of scientific products commercialized in Oregon, and 3) translate these licensable products into new, Oregon-based biotech companies, resulting in a net increase in high-paying sustainable jobs.
- Commercialization and Accelerated Drug Discovery: OTRADI adds intrinsic value to Oregon researchers' scientific intellectual property, which will accelerate external licensing of products and advance business and job creation in Oregon. As a drug commercialization accelerator, OTRADI fills a critical gap in Oregon's drug development pipeline by providing state-of-the-art, high-capacity screening to identify compounds with drug activity. For the first time, OTRADI provides Oregon research laboratories and companies with access to previously out-of-reach drug screening and testing equipment, as well as the expertise necessary to analyze results and quickly bring products to market. The return for Oregon is manifold. Drug development revenues and rights stay in the state, creating high-wage jobs and economic opportunity. New companies spin off Oregon's emerging bioscience cluster and subclusters follow, with product development services, technology and licensing capabilities.